North America Topical Skin Treatment Market Size, Share & Trends Analysis Report By Therapeutic Area (Skin Cancer, Eczema, Psoriasis), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED: September 12, 2024

PAGES: 121 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

The North America topical skin treatment market size is anticipated to reach USD 12.45 billion by 2030, growing at a CAGR of 9.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. The topical skin treatment market in North America is seeing steady growth, fueled by several key factors. Rising rates of skin conditions like acne, eczema, psoriasis, and dermatitis have created a growing need for effective treatments. Consumers are becoming more aware of skincare and showing a clear preference for over-the-counter (OTC) solutions, further boosting demand. Additionally, as the population ages, there is increasing interest in products that address skin aging concerns, such as wrinkles and age spots.

Advancements in biotechnology, especially in areas like nanotechnology and drug delivery systems, are paving the way for more effective and targeted treatments. The trend toward personalized skincare, driven by breakthroughs in genomics and artificial intelligence, is also a promising avenue for growth.

The market for topical treatments targeting Nonmelanoma Skin Cancer (NMSC) in North America is expected to witness significant advancements, particularly in innovative drug delivery systems like topical patches. These advancements aim to address the limitations of conventional topical therapies, such as poor drug penetration, local adverse effects, and patient adherence challenges.

Increasing consumer awareness about skincare and the availability of advanced acne treatments is one of the major factors expected to drive demand. The rise of e-commerce platforms, such as Amazon and Walmart, has made these treatments more accessible, contributing to the growth of retail and online pharmacies. Moreover, the convenience and variety offered by these platforms have encouraged more consumers to seek out and purchase acne treatments.

Continuous innovations in acne treatment options are crucial growth drivers. Companies like Sun Pharma and Galderma have introduced new products, such as Winlevi and TWYNEO Cream, respectively, which offer novel & effective solutions for acne treatment. These products provide better outcomes with fewer adverse effects, meeting the evolving needs of consumers and driving growth.

Strategic mergers & acquisitions, along with product launches, play a significant role in industry expansion. For instance, in January 2022, Journey Medical Corporation acquired FDA-approved topical minocycline products, expanding its product portfolio and geographical reach. In addition, in August 2021, Sun Pharma and Cassiopea partnered for the distribution of Winlevi in the U.S. and Canada, highlighting the strategic moves companies are making to enhance their commercial presence.

North America Topical Skin Treatment Market Report Highlights:

Based on therapeutic area, the Eczema segment dominated the market in 2023 and is anticipated to grow significantly over the forecast period. This growth is attributed due to the rising prevalence of eczema, increasing awareness, and growing pediatric and geriatric populations.
Based on distribution channel, the retail pharmacies segment dominated the market in 2023. This dominance is attributed due to their widespread accessibility and consumer trust, convenience of obtaining products without a prescription, and personalized guidance from pharmacists.
U.S. dominated the North America market for topical skin treatment owing to its robust healthcare infrastructure, high healthcare expenditure, and a well-established pharmaceutical industry. Furthermore, the availability of advanced treatment options, coupled with strong promotional efforts from pharmaceutical companies, ensures high consumer awareness and access.

Product Code: GVR-4-68040-450-2

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Therapeutic Areas
- 1.2.2. Distribution Channel
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Therapeutic Areas outlook
- 2.2.2. Distribution Channel outlook
- 2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. North America Topical Skin Treatment Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. High prevalence of skin diseases
  - 3.2.1.2. Increasing adoption of topical treatments
  - 3.2.1.3. Growing demand for faster and more effective results
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Skin irritation and allergies caused by topical drugs
  - 3.2.2.2. Preference for alternative modes of drug delivery
- 3.2.3. Market opportunity analysis
  - 3.2.3.1. Emerging biologic topical treatments for psoriasis
  - 3.2.3.2. Innovative topical therapies for nonmelanoma skin cancer
  - 3.2.3.3. Growth potential in advanced acne treatment solutions
3.3. North America Topical Skin Treatment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape
- 3.3.3. Pricing Analysis

Chapter 4. North America Topical Skin Treatment Market: Therapeutic Areas Estimates & Trend Analysis

4.1. North America Topical Skin Treatment Market: Therapeutic Areas Dashboard
4.2. North America Topical Skin Treatment Market: Therapeutic Areas Movement Analysis
4.3. North America Topical Skin Treatment Market: By Therapeutic Areas, Revenue (USD million)
4.4. Skin Cancer
- 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Fluorouracil (5-FU)
  - 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Imiquimod
  - 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Ingenol Mebutate
  - 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.5. Diclofenac Sodium Gel
  - 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.6. Tirbanibulin Ointment
  - 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.7. Others
  - 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Eczema
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. Corticosteroids
  - 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Calcineurin Inhibitors
  - 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.4. Crisaborole (Eucrisa)
  - 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.5. Topical Antimicrobials
  - 4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.6. Emollients and Moisturizers
  - 4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.7. Others
  - 4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Psoriasis
- 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.2. Corticosteroids
  - 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.3. Vitamin D Analogues
  - 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.4. Coal Tar
  - 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.5. Tazarotene
  - 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.6. Topical Calcineurin Inhibitors
  - 4.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.7. Combination Therapies
  - 4.6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.8. Others
  - 4.6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Other therapeutic areas
- 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America topical skin treatment market: Distribution Channel Estimates & Trend Analysis

5.1. North America topical skin treatment market: Distribution Channel Dashboard
5.2. North America topical skin treatment market: Distribution Channel Movement Analysis
5.3. North America topical skin treatment market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
5.4. Hospital Pharmacies
- 5.4.1. Hospital pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Retail Pharmacies
- 5.5.1. Retail pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Others
- 5.6.1. Online pharmacies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. North America topical skin treatment market: Regional Estimates & Trend Analysis By Therapeutic Areas, and Distribution Channel

6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
- 6.3.1. U.S.
  - 6.3.1.1. Key country dynamics
  - 6.3.1.2. Regulatory framework/ reimbursement structure
  - 6.3.1.3. Competitive scenario
  - 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2. Canada
  - 6.3.2.1. Key country dynamics
  - 6.3.2.2. Regulatory framework/ reimbursement structure
  - 6.3.2.3. Competitive scenario
  - 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.3. Mexico
  - 6.3.3.1. Key country dynamics
  - 6.3.3.2. Regulatory framework/ reimbursement structure
  - 6.3.3.3. Competitive scenario
  - 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
- 7.3.1. Key company market share analysis, 2023
- 7.3.2. Johnson & Johnson Services, Inc.
  - 7.3.2.1. Company overview
  - 7.3.2.2. Financial performance
  - 7.3.2.3. Product benchmarking
  - 7.3.2.4. Strategic initiatives
- 7.3.3. GSK Plc
  - 7.3.3.1. Company overview
  - 7.3.3.2. Financial performance
  - 7.3.3.3. Product benchmarking
  - 7.3.3.4. Strategic initiatives
- 7.3.4. Pfizer, Inc.
  - 7.3.4.1. Company overview
  - 7.3.4.2. Financial performance
  - 7.3.4.3. Product benchmarking
  - 7.3.4.4. Strategic initiatives
- 7.3.5. Novartis AG
  - 7.3.5.1. Company overview
  - 7.3.5.2. Financial performance
  - 7.3.5.3. Product benchmarking
  - 7.3.5.4. Strategic initiatives
- 7.3.6. LEO Pharma A/S
  - 7.3.6.1. Company overview
  - 7.3.6.2. Financial performance
  - 7.3.6.3. Product benchmarking
  - 7.3.6.4. Strategic initiatives
- 7.3.7. AbbVie, Inc.
  - 7.3.7.1. Company overview
  - 7.3.7.2. Financial performance
  - 7.3.7.3. Product benchmarking
  - 7.3.7.4. Strategic initiatives
- 7.3.8. Bausch Health Companies, Inc.
  - 7.3.8.1. Company overview
  - 7.3.8.2. Financial performance
  - 7.3.8.3. Product benchmarking
  - 7.3.8.4. Strategic initiatives
- 7.3.9. Galderma
  - 7.3.9.1. Company overview
  - 7.3.9.2. Financial performance
  - 7.3.9.3. Product benchmarking
  - 7.3.9.4. Strategic initiatives
- 7.3.10. Sun Pharmaceutical Industries Ltd.
  - 7.3.10.1. Company overview
  - 7.3.10.2. Financial performance
  - 7.3.10.3. Product benchmarking
  - 7.3.10.4. Strategic initiatives

Product Code: GVR-4-68040-450-2

List of Tables

Table 1 List of abbreviation
Table 2 North America topical skin treatment market, by region, 2018 - 2030 (USD Million)
Table 3 North America topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 4 North America topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 5 U.S. North America topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 6 U.S. topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Canada topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 8 Canada topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 Mexico topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 10 Mexico topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 North America Topical Skin Treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic areas and distribution channel snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Pharmaceutical market value, 2023 (USD billion)
Fig. 12 Market trends & outlook
Fig. 13 Melanoma cases in 2021
Fig. 14 Porter's five force analysis
Fig. 15 PESTEL analysis
Fig. 16 North America topical skin treatment market: Therapeutic areas outlook and key takeaways
Fig. 17 North America topical skin treatment market: Therapeutic areas movement analysis
Fig. 18 Skin cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Skin cancer cases in 2022
Fig. 20 Fluorouracil (5-FU) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Imiquimod market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Ingenol mebutate market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Diclofenac sodium gel market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Tirbanibulin ointment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Eczema market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Prevalence of Atopic Dermatitis (AD) in 2023
Fig. 28 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Calcineurin inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Crisaborole (Eucrisa) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Topical antimicrobials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Emollients and moisturizers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Psoriasis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Psoriasis cases (Million)
Fig. 36 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Vitamin D analogs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Coal tar market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Tazarotene market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Topical calcineurin inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Combination therapies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 North America topical skin treatment market: Distribution channel outlook and key takeaways
Fig. 45 North America topical skin treatment market: Distribution channel movement analysis
Fig. 46 Skin cancer, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Skin cancer, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Skin cancer, other, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Eczema, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Eczema, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Eczema, other, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Psoriasis, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Psoriasis, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Psoriasis, other, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Other, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Other, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 North America topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 U.S. North America Topical Skin Treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Canada topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Mexico topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Market participant categorization
Fig. 66 Company market share analysis, 2023
Fig. 67 Strategic framework